When bred to a VavP-Bcl2 mice, RagC-Bcl2+ double-mutant mice showed exacerbated B cell responses in response to immunization characterized by enlarged GCs, increased plasma cell production without impairment of high-affinity B cell selection and eventually acceleration of lymphoma development. The gene discussed is BCL2; the disease is lymphoma.